Revium Recovery Inc.
Get $10 bonus on your first $100 deposit for RVRC
Get $10 bonus on your first $100 deposit for RVRC
Revium Recovery Inc. (RVRC) Stock Competitors & Peer Comparison
See (RVRC) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RVRC | $1.67 | +0.00% | 130.8K | -0.35 | -$4.72 | N/A |
| PMCUF | $83.00 | +1.28% | 8.7B | 53.55 | $1.55 | +0.51% |
| MTHRF | $11.00 | +0.00% | 7.5B | 26.19 | $0.42 | +1.19% |
| MTHRY | $5.16 | -1.53% | 7B | 24.57 | $0.21 | N/A |
| PANHF | $1.55 | -12.22% | 3.3B | 154.50 | $0.01 | N/A |
| PIAHY | $4.40 | +0.00% | 2.3B | 88.00 | $0.05 | N/A |
| CMPVF | $33.66 | +11.64% | 1.7B | 58.03 | $0.58 | +0.17% |
| CMPUY | $23.00 | -7.26% | 1.2B | 38.98 | $0.59 | N/A |
| CRWRF | $24.20 | +0.00% | 850.7M | 44.00 | $0.55 | +1.84% |
| RSLBF | $20.95 | +0.00% | 748.9M | 29.51 | $0.71 | +1.50% |
Stock Comparison
RVRC vs PMCUF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, PMCUF has a market cap of 8.7B. Regarding current trading prices, RVRC is priced at $1.67, while PMCUF trades at $83.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas PMCUF's P/E ratio is 53.55. In terms of profitability, RVRC's ROE is +0.07%, compared to PMCUF's ROE of +0.73%. Regarding short-term risk, RVRC is less volatile compared to PMCUF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check PMCUF's competition here
RVRC vs MTHRF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, MTHRF has a market cap of 7.5B. Regarding current trading prices, RVRC is priced at $1.67, while MTHRF trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas MTHRF's P/E ratio is 26.19. In terms of profitability, RVRC's ROE is +0.07%, compared to MTHRF's ROE of +0.18%. Regarding short-term risk, RVRC and MTHRF have similar daily volatility (0.00).Check MTHRF's competition here
RVRC vs MTHRY Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, MTHRY has a market cap of 7B. Regarding current trading prices, RVRC is priced at $1.67, while MTHRY trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas MTHRY's P/E ratio is 24.57. In terms of profitability, RVRC's ROE is +0.07%, compared to MTHRY's ROE of +0.13%. Regarding short-term risk, RVRC is less volatile compared to MTHRY. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check MTHRY's competition here
RVRC vs PANHF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, PANHF has a market cap of 3.3B. Regarding current trading prices, RVRC is priced at $1.67, while PANHF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas PANHF's P/E ratio is 154.50. In terms of profitability, RVRC's ROE is +0.07%, compared to PANHF's ROE of +0.04%. Regarding short-term risk, RVRC and PANHF have similar daily volatility (0.00).Check PANHF's competition here
RVRC vs PIAHY Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, PIAHY has a market cap of 2.3B. Regarding current trading prices, RVRC is priced at $1.67, while PIAHY trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas PIAHY's P/E ratio is 88.00. In terms of profitability, RVRC's ROE is +0.07%, compared to PIAHY's ROE of +0.04%. Regarding short-term risk, RVRC is less volatile compared to PIAHY. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check PIAHY's competition here
RVRC vs CMPVF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, CMPVF has a market cap of 1.7B. Regarding current trading prices, RVRC is priced at $1.67, while CMPVF trades at $33.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas CMPVF's P/E ratio is 58.03. In terms of profitability, RVRC's ROE is +0.07%, compared to CMPVF's ROE of +0.03%. Regarding short-term risk, RVRC is less volatile compared to CMPVF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check CMPVF's competition here
RVRC vs CMPUY Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, CMPUY has a market cap of 1.2B. Regarding current trading prices, RVRC is priced at $1.67, while CMPUY trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas CMPUY's P/E ratio is 38.98. In terms of profitability, RVRC's ROE is +0.07%, compared to CMPUY's ROE of +0.01%. Regarding short-term risk, RVRC and CMPUY have similar daily volatility (0.00).Check CMPUY's competition here
RVRC vs CRWRF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, CRWRF has a market cap of 850.7M. Regarding current trading prices, RVRC is priced at $1.67, while CRWRF trades at $24.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas CRWRF's P/E ratio is 44.00. In terms of profitability, RVRC's ROE is +0.07%, compared to CRWRF's ROE of +0.07%. Regarding short-term risk, RVRC is less volatile compared to CRWRF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check CRWRF's competition here
RVRC vs RSLBF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, RSLBF has a market cap of 748.9M. Regarding current trading prices, RVRC is priced at $1.67, while RSLBF trades at $20.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas RSLBF's P/E ratio is 29.51. In terms of profitability, RVRC's ROE is +0.07%, compared to RSLBF's ROE of +0.25%. Regarding short-term risk, RVRC and RSLBF have similar daily volatility (0.00).Check RSLBF's competition here
RVRC vs SMSZF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, SMSZF has a market cap of 702.6M. Regarding current trading prices, RVRC is priced at $1.67, while SMSZF trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas SMSZF's P/E ratio is 17.83. In terms of profitability, RVRC's ROE is +0.07%, compared to SMSZF's ROE of +0.15%. Regarding short-term risk, RVRC is less volatile compared to SMSZF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check SMSZF's competition here
RVRC vs VHIBF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, VHIBF has a market cap of 317.4M. Regarding current trading prices, RVRC is priced at $1.67, while VHIBF trades at $5.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas VHIBF's P/E ratio is 71.71. In terms of profitability, RVRC's ROE is +0.07%, compared to VHIBF's ROE of +0.03%. Regarding short-term risk, RVRC is less volatile compared to VHIBF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check VHIBF's competition here
RVRC vs SMDCF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, SMDCF has a market cap of 280.9M. Regarding current trading prices, RVRC is priced at $1.67, while SMDCF trades at $17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas SMDCF's P/E ratio is -17.32. In terms of profitability, RVRC's ROE is +0.07%, compared to SMDCF's ROE of N/A. Regarding short-term risk, RVRC and SMDCF have similar daily volatility (0.00).Check SMDCF's competition here
RVRC vs COGZF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, COGZF has a market cap of 256.5M. Regarding current trading prices, RVRC is priced at $1.67, while COGZF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas COGZF's P/E ratio is 25.00. In terms of profitability, RVRC's ROE is +0.07%, compared to COGZF's ROE of +0.29%. Regarding short-term risk, RVRC and COGZF have similar daily volatility (0.00).Check COGZF's competition here
RVRC vs DLHTF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, DLHTF has a market cap of 254.8M. Regarding current trading prices, RVRC is priced at $1.67, while DLHTF trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas DLHTF's P/E ratio is -17.24. In terms of profitability, RVRC's ROE is +0.07%, compared to DLHTF's ROE of -0.24%. Regarding short-term risk, RVRC and DLHTF have similar daily volatility (0.00).Check DLHTF's competition here
RVRC vs KSIOF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, KSIOF has a market cap of 247.1M. Regarding current trading prices, RVRC is priced at $1.67, while KSIOF trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas KSIOF's P/E ratio is -258.00. In terms of profitability, RVRC's ROE is +0.07%, compared to KSIOF's ROE of -0.04%. Regarding short-term risk, RVRC is less volatile compared to KSIOF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check KSIOF's competition here
RVRC vs VPAHF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, VPAHF has a market cap of 188.2M. Regarding current trading prices, RVRC is priced at $1.67, while VPAHF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas VPAHF's P/E ratio is -37.00. In terms of profitability, RVRC's ROE is +0.07%, compared to VPAHF's ROE of -0.18%. Regarding short-term risk, RVRC and VPAHF have similar daily volatility (0.00).Check VPAHF's competition here
RVRC vs ACMLF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, ACMLF has a market cap of 149.3M. Regarding current trading prices, RVRC is priced at $1.67, while ACMLF trades at $4.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas ACMLF's P/E ratio is 43.70. In terms of profitability, RVRC's ROE is +0.07%, compared to ACMLF's ROE of +0.20%. Regarding short-term risk, RVRC is less volatile compared to ACMLF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check ACMLF's competition here
RVRC vs SUSRF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, SUSRF has a market cap of 144.9M. Regarding current trading prices, RVRC is priced at $1.67, while SUSRF trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas SUSRF's P/E ratio is 20.29. In terms of profitability, RVRC's ROE is +0.07%, compared to SUSRF's ROE of +0.02%. Regarding short-term risk, RVRC is less volatile compared to SUSRF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check SUSRF's competition here
RVRC vs ONVVF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, ONVVF has a market cap of 122.8M. Regarding current trading prices, RVRC is priced at $1.67, while ONVVF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas ONVVF's P/E ratio is -8.00. In terms of profitability, RVRC's ROE is +0.07%, compared to ONVVF's ROE of -2.27%. Regarding short-term risk, RVRC is less volatile compared to ONVVF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check ONVVF's competition here
RVRC vs CSAMF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, CSAMF has a market cap of 98.8M. Regarding current trading prices, RVRC is priced at $1.67, while CSAMF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas CSAMF's P/E ratio is -9.64. In terms of profitability, RVRC's ROE is +0.07%, compared to CSAMF's ROE of -0.85%. Regarding short-term risk, RVRC and CSAMF have similar daily volatility (0.00).Check CSAMF's competition here
RVRC vs HITC Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, HITC has a market cap of 52.8M. Regarding current trading prices, RVRC is priced at $1.67, while HITC trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas HITC's P/E ratio is -14.75. In terms of profitability, RVRC's ROE is +0.07%, compared to HITC's ROE of -0.79%. Regarding short-term risk, RVRC is less volatile compared to HITC. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check HITC's competition here
RVRC vs MDPEF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, MDPEF has a market cap of 42.6M. Regarding current trading prices, RVRC is priced at $1.67, while MDPEF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas MDPEF's P/E ratio is 0.00. In terms of profitability, RVRC's ROE is +0.07%, compared to MDPEF's ROE of N/A. Regarding short-term risk, RVRC and MDPEF have similar daily volatility (0.00).Check MDPEF's competition here
RVRC vs TREIF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, TREIF has a market cap of 36.6M. Regarding current trading prices, RVRC is priced at $1.67, while TREIF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas TREIF's P/E ratio is -3.46. In terms of profitability, RVRC's ROE is +0.07%, compared to TREIF's ROE of -3.04%. Regarding short-term risk, RVRC is less volatile compared to TREIF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check TREIF's competition here
RVRC vs EMOR Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, EMOR has a market cap of 30.6M. Regarding current trading prices, RVRC is priced at $1.67, while EMOR trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas EMOR's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to EMOR's ROE of +0.06%. Regarding short-term risk, RVRC is less volatile compared to EMOR. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check EMOR's competition here
RVRC vs VASO Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, VASO has a market cap of 28.2M. Regarding current trading prices, RVRC is priced at $1.67, while VASO trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas VASO's P/E ratio is 16.00. In terms of profitability, RVRC's ROE is +0.07%, compared to VASO's ROE of -0.15%. Regarding short-term risk, RVRC is less volatile compared to VASO. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check VASO's competition here
RVRC vs RTNXF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, RTNXF has a market cap of 22.5M. Regarding current trading prices, RVRC is priced at $1.67, while RTNXF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas RTNXF's P/E ratio is -0.33. In terms of profitability, RVRC's ROE is +0.07%, compared to RTNXF's ROE of -6.31%. Regarding short-term risk, RVRC is less volatile compared to RTNXF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check RTNXF's competition here
RVRC vs HDSLF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, HDSLF has a market cap of 21.1M. Regarding current trading prices, RVRC is priced at $1.67, while HDSLF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas HDSLF's P/E ratio is -3.22. In terms of profitability, RVRC's ROE is +0.07%, compared to HDSLF's ROE of -1.31%. Regarding short-term risk, RVRC is less volatile compared to HDSLF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check HDSLF's competition here
RVRC vs DGNOF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, DGNOF has a market cap of 20.4M. Regarding current trading prices, RVRC is priced at $1.67, while DGNOF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas DGNOF's P/E ratio is -5.00. In terms of profitability, RVRC's ROE is +0.07%, compared to DGNOF's ROE of +30.80%. Regarding short-term risk, RVRC is less volatile compared to DGNOF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check DGNOF's competition here
RVRC vs THKKF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, THKKF has a market cap of 17.8M. Regarding current trading prices, RVRC is priced at $1.67, while THKKF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas THKKF's P/E ratio is -1.51. In terms of profitability, RVRC's ROE is +0.07%, compared to THKKF's ROE of -0.61%. Regarding short-term risk, RVRC and THKKF have similar daily volatility (0.00).Check THKKF's competition here
RVRC vs CRVW Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, CRVW has a market cap of 17.5M. Regarding current trading prices, RVRC is priced at $1.67, while CRVW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas CRVW's P/E ratio is -3.00. In terms of profitability, RVRC's ROE is +0.07%, compared to CRVW's ROE of +0.10%. Regarding short-term risk, RVRC is less volatile compared to CRVW. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check CRVW's competition here
RVRC vs MNNDF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, MNNDF has a market cap of 14.3M. Regarding current trading prices, RVRC is priced at $1.67, while MNNDF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas MNNDF's P/E ratio is -1.48. In terms of profitability, RVRC's ROE is +0.07%, compared to MNNDF's ROE of N/A. Regarding short-term risk, RVRC is less volatile compared to MNNDF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check MNNDF's competition here
RVRC vs WLSS Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, WLSS has a market cap of 12.7M. Regarding current trading prices, RVRC is priced at $1.67, while WLSS trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas WLSS's P/E ratio is -460.00. In terms of profitability, RVRC's ROE is +0.07%, compared to WLSS's ROE of +0.33%. Regarding short-term risk, RVRC is less volatile compared to WLSS. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check WLSS's competition here
RVRC vs PBSV Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, PBSV has a market cap of 11.7M. Regarding current trading prices, RVRC is priced at $1.67, while PBSV trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas PBSV's P/E ratio is -51.00. In terms of profitability, RVRC's ROE is +0.07%, compared to PBSV's ROE of -0.00%. Regarding short-term risk, RVRC is less volatile compared to PBSV. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check PBSV's competition here
RVRC vs BRGX Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, BRGX has a market cap of 11.1M. Regarding current trading prices, RVRC is priced at $1.67, while BRGX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas BRGX's P/E ratio is -1.16. In terms of profitability, RVRC's ROE is +0.07%, compared to BRGX's ROE of +5.32%. Regarding short-term risk, RVRC is less volatile compared to BRGX. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check BRGX's competition here
RVRC vs CMHSF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, CMHSF has a market cap of 9.9M. Regarding current trading prices, RVRC is priced at $1.67, while CMHSF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas CMHSF's P/E ratio is -3.67. In terms of profitability, RVRC's ROE is +0.07%, compared to CMHSF's ROE of +0.28%. Regarding short-term risk, RVRC is less volatile compared to CMHSF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check CMHSF's competition here
RVRC vs CDXFF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, CDXFF has a market cap of 9.7M. Regarding current trading prices, RVRC is priced at $1.67, while CDXFF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas CDXFF's P/E ratio is -1.35. In terms of profitability, RVRC's ROE is +0.07%, compared to CDXFF's ROE of +0.70%. Regarding short-term risk, RVRC and CDXFF have similar daily volatility (0.00).Check CDXFF's competition here
RVRC vs CMPD Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, CMPD has a market cap of 8.8M. Regarding current trading prices, RVRC is priced at $1.67, while CMPD trades at $6.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas CMPD's P/E ratio is -15.11. In terms of profitability, RVRC's ROE is +0.07%, compared to CMPD's ROE of -0.04%. Regarding short-term risk, RVRC is less volatile compared to CMPD. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check CMPD's competition here
RVRC vs HBCNF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, HBCNF has a market cap of 8.4M. Regarding current trading prices, RVRC is priced at $1.67, while HBCNF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas HBCNF's P/E ratio is -0.59. In terms of profitability, RVRC's ROE is +0.07%, compared to HBCNF's ROE of -0.57%. Regarding short-term risk, RVRC is less volatile compared to HBCNF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check HBCNF's competition here
RVRC vs SPLTF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, SPLTF has a market cap of 8M. Regarding current trading prices, RVRC is priced at $1.67, while SPLTF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas SPLTF's P/E ratio is -2.60. In terms of profitability, RVRC's ROE is +0.07%, compared to SPLTF's ROE of -6.63%. Regarding short-term risk, RVRC is less volatile compared to SPLTF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check SPLTF's competition here
RVRC vs VYND Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, VYND has a market cap of 7.9M. Regarding current trading prices, RVRC is priced at $1.67, while VYND trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas VYND's P/E ratio is -43.00. In terms of profitability, RVRC's ROE is +0.07%, compared to VYND's ROE of +0.81%. Regarding short-term risk, RVRC and VYND have similar daily volatility (0.00).Check VYND's competition here
RVRC vs UDOCF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, UDOCF has a market cap of 7.7M. Regarding current trading prices, RVRC is priced at $1.67, while UDOCF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas UDOCF's P/E ratio is -2.97. In terms of profitability, RVRC's ROE is +0.07%, compared to UDOCF's ROE of +62.04%. Regarding short-term risk, RVRC and UDOCF have similar daily volatility (0.00).Check UDOCF's competition here
RVRC vs CRBKF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, CRBKF has a market cap of 6.8M. Regarding current trading prices, RVRC is priced at $1.67, while CRBKF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas CRBKF's P/E ratio is -1.40. In terms of profitability, RVRC's ROE is +0.07%, compared to CRBKF's ROE of +68.80%. Regarding short-term risk, RVRC and CRBKF have similar daily volatility (0.00).Check CRBKF's competition here
RVRC vs DOCRF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, DOCRF has a market cap of 6.2M. Regarding current trading prices, RVRC is priced at $1.67, while DOCRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas DOCRF's P/E ratio is -0.11. In terms of profitability, RVRC's ROE is +0.07%, compared to DOCRF's ROE of -1.12%. Regarding short-term risk, RVRC and DOCRF have similar daily volatility (0.00).Check DOCRF's competition here
RVRC vs IQAIF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, IQAIF has a market cap of 4.9M. Regarding current trading prices, RVRC is priced at $1.67, while IQAIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas IQAIF's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to IQAIF's ROE of -0.17%. Regarding short-term risk, RVRC is less volatile compared to IQAIF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check IQAIF's competition here
RVRC vs CBDS Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, CBDS has a market cap of 4.3M. Regarding current trading prices, RVRC is priced at $1.67, while CBDS trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas CBDS's P/E ratio is -1.49. In terms of profitability, RVRC's ROE is +0.07%, compared to CBDS's ROE of +0.68%. Regarding short-term risk, RVRC is less volatile compared to CBDS. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check CBDS's competition here
RVRC vs AIMLF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, AIMLF has a market cap of 4.1M. Regarding current trading prices, RVRC is priced at $1.67, while AIMLF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas AIMLF's P/E ratio is -1.23. In terms of profitability, RVRC's ROE is +0.07%, compared to AIMLF's ROE of -3.31%. Regarding short-term risk, RVRC is less volatile compared to AIMLF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check AIMLF's competition here
RVRC vs RQHTF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, RQHTF has a market cap of 2.6M. Regarding current trading prices, RVRC is priced at $1.67, while RQHTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas RQHTF's P/E ratio is -0.07. In terms of profitability, RVRC's ROE is +0.07%, compared to RQHTF's ROE of -2.22%. Regarding short-term risk, RVRC and RQHTF have similar daily volatility (0.00).Check RQHTF's competition here
RVRC vs NDATF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, NDATF has a market cap of 2.5M. Regarding current trading prices, RVRC is priced at $1.67, while NDATF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas NDATF's P/E ratio is -6.00. In terms of profitability, RVRC's ROE is +0.07%, compared to NDATF's ROE of -0.64%. Regarding short-term risk, RVRC and NDATF have similar daily volatility (0.00).Check NDATF's competition here
RVRC vs CSOC Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, CSOC has a market cap of 2.4M. Regarding current trading prices, RVRC is priced at $1.67, while CSOC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas CSOC's P/E ratio is 0.28. In terms of profitability, RVRC's ROE is +0.07%, compared to CSOC's ROE of -3.87%. Regarding short-term risk, RVRC is less volatile compared to CSOC. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check CSOC's competition here
RVRC vs RYAHF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, RYAHF has a market cap of 2.2M. Regarding current trading prices, RVRC is priced at $1.67, while RYAHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas RYAHF's P/E ratio is 0.25. In terms of profitability, RVRC's ROE is +0.07%, compared to RYAHF's ROE of +14.95%. Regarding short-term risk, RVRC and RYAHF have similar daily volatility (0.00).Check RYAHF's competition here
RVRC vs RSLT Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, RSLT has a market cap of 2.2M. Regarding current trading prices, RVRC is priced at $1.67, while RSLT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas RSLT's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to RSLT's ROE of N/A. Regarding short-term risk, RVRC is less volatile compared to RSLT. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check RSLT's competition here
RVRC vs EBYH Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, EBYH has a market cap of 1.9M. Regarding current trading prices, RVRC is priced at $1.67, while EBYH trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas EBYH's P/E ratio is -5.42. In terms of profitability, RVRC's ROE is +0.07%, compared to EBYH's ROE of +0.09%. Regarding short-term risk, RVRC is less volatile compared to EBYH. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check EBYH's competition here
RVRC vs MDBIF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, MDBIF has a market cap of 1.6M. Regarding current trading prices, RVRC is priced at $1.67, while MDBIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas MDBIF's P/E ratio is -0.25. In terms of profitability, RVRC's ROE is +0.07%, compared to MDBIF's ROE of -0.12%. Regarding short-term risk, RVRC is less volatile compared to MDBIF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check MDBIF's competition here
RVRC vs MITI Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, MITI has a market cap of 952.2K. Regarding current trading prices, RVRC is priced at $1.67, while MITI trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas MITI's P/E ratio is -0.12. In terms of profitability, RVRC's ROE is +0.07%, compared to MITI's ROE of +0.17%. Regarding short-term risk, RVRC is less volatile compared to MITI. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check MITI's competition here
RVRC vs EKGGF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, EKGGF has a market cap of 908.9K. Regarding current trading prices, RVRC is priced at $1.67, while EKGGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas EKGGF's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to EKGGF's ROE of +1.04%. Regarding short-term risk, RVRC is less volatile compared to EKGGF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check EKGGF's competition here
RVRC vs EVAHF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, EVAHF has a market cap of 662.2K. Regarding current trading prices, RVRC is priced at $1.67, while EVAHF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas EVAHF's P/E ratio is -0.27. In terms of profitability, RVRC's ROE is +0.07%, compared to EVAHF's ROE of +0.78%. Regarding short-term risk, RVRC and EVAHF have similar daily volatility (0.00).Check EVAHF's competition here
RVRC vs DSOL Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, DSOL has a market cap of 622.2K. Regarding current trading prices, RVRC is priced at $1.67, while DSOL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas DSOL's P/E ratio is -0.02. In terms of profitability, RVRC's ROE is +0.07%, compared to DSOL's ROE of +0.03%. Regarding short-term risk, RVRC and DSOL have similar daily volatility (0.00).Check DSOL's competition here
RVRC vs DTRK Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, DTRK has a market cap of 549.5K. Regarding current trading prices, RVRC is priced at $1.67, while DTRK trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas DTRK's P/E ratio is -4.78. In terms of profitability, RVRC's ROE is +0.07%, compared to DTRK's ROE of +3.54%. Regarding short-term risk, RVRC is less volatile compared to DTRK. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check DTRK's competition here
RVRC vs MDNWF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, MDNWF has a market cap of 517.3K. Regarding current trading prices, RVRC is priced at $1.67, while MDNWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas MDNWF's P/E ratio is -0.02. In terms of profitability, RVRC's ROE is +0.07%, compared to MDNWF's ROE of -1.53%. Regarding short-term risk, RVRC is less volatile compared to MDNWF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check MDNWF's competition here
RVRC vs USPS Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, USPS has a market cap of 455.1K. Regarding current trading prices, RVRC is priced at $1.67, while USPS trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas USPS's P/E ratio is -2.87. In terms of profitability, RVRC's ROE is +0.07%, compared to USPS's ROE of +0.62%. Regarding short-term risk, RVRC is less volatile compared to USPS. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check USPS's competition here
RVRC vs PPJE Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, PPJE has a market cap of 445.2K. Regarding current trading prices, RVRC is priced at $1.67, while PPJE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas PPJE's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to PPJE's ROE of -0.00%. Regarding short-term risk, RVRC is less volatile compared to PPJE. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check PPJE's competition here
RVRC vs CTVEF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, CTVEF has a market cap of 418.1K. Regarding current trading prices, RVRC is priced at $1.67, while CTVEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas CTVEF's P/E ratio is -0.16. In terms of profitability, RVRC's ROE is +0.07%, compared to CTVEF's ROE of +0.17%. Regarding short-term risk, RVRC is less volatile compared to CTVEF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check CTVEF's competition here
RVRC vs LVCE Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, LVCE has a market cap of 381.9K. Regarding current trading prices, RVRC is priced at $1.67, while LVCE trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas LVCE's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to LVCE's ROE of N/A. Regarding short-term risk, RVRC is less volatile compared to LVCE. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check LVCE's competition here
RVRC vs ACHKF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, ACHKF has a market cap of 377.4K. Regarding current trading prices, RVRC is priced at $1.67, while ACHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas ACHKF's P/E ratio is -0.05. In terms of profitability, RVRC's ROE is +0.07%, compared to ACHKF's ROE of +2.16%. Regarding short-term risk, RVRC and ACHKF have similar daily volatility (0.00).Check ACHKF's competition here
RVRC vs NHIQ Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, NHIQ has a market cap of 329.7K. Regarding current trading prices, RVRC is priced at $1.67, while NHIQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas NHIQ's P/E ratio is -0.00. In terms of profitability, RVRC's ROE is +0.07%, compared to NHIQ's ROE of +0.35%. Regarding short-term risk, RVRC is less volatile compared to NHIQ. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check NHIQ's competition here
RVRC vs MDRM Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, MDRM has a market cap of 255.1K. Regarding current trading prices, RVRC is priced at $1.67, while MDRM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas MDRM's P/E ratio is -0.20. In terms of profitability, RVRC's ROE is +0.07%, compared to MDRM's ROE of +0.42%. Regarding short-term risk, RVRC is less volatile compared to MDRM. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check MDRM's competition here
RVRC vs EWLL Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, EWLL has a market cap of 185.1K. Regarding current trading prices, RVRC is priced at $1.67, while EWLL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas EWLL's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to EWLL's ROE of +0.13%. Regarding short-term risk, RVRC is less volatile compared to EWLL. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check EWLL's competition here
RVRC vs ALDNF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, ALDNF has a market cap of 160.4K. Regarding current trading prices, RVRC is priced at $1.67, while ALDNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas ALDNF's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to ALDNF's ROE of +0.55%. Regarding short-term risk, RVRC and ALDNF have similar daily volatility (0.00).Check ALDNF's competition here
RVRC vs TSTTF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, TSTTF has a market cap of 145.8K. Regarding current trading prices, RVRC is priced at $1.67, while TSTTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas TSTTF's P/E ratio is -0.73. In terms of profitability, RVRC's ROE is +0.07%, compared to TSTTF's ROE of -0.02%. Regarding short-term risk, RVRC is less volatile compared to TSTTF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check TSTTF's competition here
RVRC vs EMYSF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, EMYSF has a market cap of 142.2K. Regarding current trading prices, RVRC is priced at $1.67, while EMYSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas EMYSF's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to EMYSF's ROE of +2.20%. Regarding short-term risk, RVRC is less volatile compared to EMYSF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check EMYSF's competition here
RVRC vs NEWUF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, NEWUF has a market cap of 86.6K. Regarding current trading prices, RVRC is priced at $1.67, while NEWUF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas NEWUF's P/E ratio is -0.02. In terms of profitability, RVRC's ROE is +0.07%, compared to NEWUF's ROE of +0.88%. Regarding short-term risk, RVRC and NEWUF have similar daily volatility (0.00).Check NEWUF's competition here
RVRC vs PASO Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, PASO has a market cap of 74.1K. Regarding current trading prices, RVRC is priced at $1.67, while PASO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas PASO's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to PASO's ROE of +6.20%. Regarding short-term risk, RVRC and PASO have similar daily volatility (0.00).Check PASO's competition here
RVRC vs LFCOF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, LFCOF has a market cap of 71.6K. Regarding current trading prices, RVRC is priced at $1.67, while LFCOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas LFCOF's P/E ratio is -0.04. In terms of profitability, RVRC's ROE is +0.07%, compared to LFCOF's ROE of +8.70%. Regarding short-term risk, RVRC is less volatile compared to LFCOF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check LFCOF's competition here
RVRC vs REFG Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, REFG has a market cap of 60.8K. Regarding current trading prices, RVRC is priced at $1.67, while REFG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas REFG's P/E ratio is -0.01. In terms of profitability, RVRC's ROE is +0.07%, compared to REFG's ROE of +0.01%. Regarding short-term risk, RVRC and REFG have similar daily volatility (0.00).Check REFG's competition here
RVRC vs SOFE Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, SOFE has a market cap of 45.1K. Regarding current trading prices, RVRC is priced at $1.67, while SOFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas SOFE's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to SOFE's ROE of +0.52%. Regarding short-term risk, RVRC is less volatile compared to SOFE. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check SOFE's competition here
RVRC vs HDVY Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, HDVY has a market cap of 41.2K. Regarding current trading prices, RVRC is priced at $1.67, while HDVY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas HDVY's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to HDVY's ROE of +15.89%. Regarding short-term risk, RVRC and HDVY have similar daily volatility (0.00).Check HDVY's competition here
RVRC vs MDXL Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, MDXL has a market cap of 41.1K. Regarding current trading prices, RVRC is priced at $1.67, while MDXL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas MDXL's P/E ratio is -0.01. In terms of profitability, RVRC's ROE is +0.07%, compared to MDXL's ROE of +0.90%. Regarding short-term risk, RVRC is less volatile compared to MDXL. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check MDXL's competition here
RVRC vs IGRW Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, IGRW has a market cap of 39.8K. Regarding current trading prices, RVRC is priced at $1.67, while IGRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas IGRW's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to IGRW's ROE of -2.28%. Regarding short-term risk, RVRC is less volatile compared to IGRW. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check IGRW's competition here
RVRC vs WMGR Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, WMGR has a market cap of 36.3K. Regarding current trading prices, RVRC is priced at $1.67, while WMGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas WMGR's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to WMGR's ROE of +0.53%. Regarding short-term risk, RVRC and WMGR have similar daily volatility (0.00).Check WMGR's competition here
RVRC vs SSYNF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, SSYNF has a market cap of 33.3K. Regarding current trading prices, RVRC is priced at $1.67, while SSYNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas SSYNF's P/E ratio is -0.00. In terms of profitability, RVRC's ROE is +0.07%, compared to SSYNF's ROE of N/A. Regarding short-term risk, RVRC and SSYNF have similar daily volatility (0.00).Check SSYNF's competition here
RVRC vs TTBLF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, TTBLF has a market cap of 26.7K. Regarding current trading prices, RVRC is priced at $1.67, while TTBLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas TTBLF's P/E ratio is -0.00. In terms of profitability, RVRC's ROE is +0.07%, compared to TTBLF's ROE of -1.03%. Regarding short-term risk, RVRC is less volatile compared to TTBLF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check TTBLF's competition here
RVRC vs FDBH Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, FDBH has a market cap of 25K. Regarding current trading prices, RVRC is priced at $1.67, while FDBH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas FDBH's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to FDBH's ROE of +0.32%. Regarding short-term risk, RVRC is less volatile compared to FDBH. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check FDBH's competition here
RVRC vs NMXS Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, NMXS has a market cap of 18.8K. Regarding current trading prices, RVRC is priced at $1.67, while NMXS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas NMXS's P/E ratio is -0.05. In terms of profitability, RVRC's ROE is +0.07%, compared to NMXS's ROE of -2.50%. Regarding short-term risk, RVRC is less volatile compared to NMXS. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check NMXS's competition here
RVRC vs NHEL Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, NHEL has a market cap of 16.2K. Regarding current trading prices, RVRC is priced at $1.67, while NHEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas NHEL's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to NHEL's ROE of +7.36%. Regarding short-term risk, RVRC and NHEL have similar daily volatility (0.00).Check NHEL's competition here
RVRC vs ORHB Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, ORHB has a market cap of 13.8K. Regarding current trading prices, RVRC is priced at $1.67, while ORHB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas ORHB's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to ORHB's ROE of +1.70%. Regarding short-term risk, RVRC and ORHB have similar daily volatility (0.00).Check ORHB's competition here
RVRC vs BNVIF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, BNVIF has a market cap of 13.3K. Regarding current trading prices, RVRC is priced at $1.67, while BNVIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas BNVIF's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to BNVIF's ROE of -4.34%. Regarding short-term risk, RVRC is less volatile compared to BNVIF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check BNVIF's competition here
RVRC vs HLTT Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, HLTT has a market cap of 10.7K. Regarding current trading prices, RVRC is priced at $1.67, while HLTT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas HLTT's P/E ratio is -0.00. In terms of profitability, RVRC's ROE is +0.07%, compared to HLTT's ROE of +1789941.38%. Regarding short-term risk, RVRC and HLTT have similar daily volatility (0.00).Check HLTT's competition here
RVRC vs CGNSF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, CGNSF has a market cap of 9K. Regarding current trading prices, RVRC is priced at $1.67, while CGNSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas CGNSF's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to CGNSF's ROE of +0.96%. Regarding short-term risk, RVRC is less volatile compared to CGNSF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check CGNSF's competition here
RVRC vs MOSTQ Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, MOSTQ has a market cap of 8.5K. Regarding current trading prices, RVRC is priced at $1.67, while MOSTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas MOSTQ's P/E ratio is -0.00. In terms of profitability, RVRC's ROE is +0.07%, compared to MOSTQ's ROE of +2.26%. Regarding short-term risk, RVRC and MOSTQ have similar daily volatility (0.00).Check MOSTQ's competition here
RVRC vs ACNV Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, ACNV has a market cap of 8.1K. Regarding current trading prices, RVRC is priced at $1.67, while ACNV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas ACNV's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to ACNV's ROE of +0.85%. Regarding short-term risk, RVRC and ACNV have similar daily volatility (0.00).Check ACNV's competition here
RVRC vs AHGIF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, AHGIF has a market cap of 7.8K. Regarding current trading prices, RVRC is priced at $1.67, while AHGIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas AHGIF's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to AHGIF's ROE of -2.79%. Regarding short-term risk, RVRC is less volatile compared to AHGIF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check AHGIF's competition here
RVRC vs BBLNF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, BBLNF has a market cap of 2.6K. Regarding current trading prices, RVRC is priced at $1.67, while BBLNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas BBLNF's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to BBLNF's ROE of +1.06%. Regarding short-term risk, RVRC and BBLNF have similar daily volatility (0.00).Check BBLNF's competition here
RVRC vs ICCO Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, ICCO has a market cap of 2K. Regarding current trading prices, RVRC is priced at $1.67, while ICCO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas ICCO's P/E ratio is -0.01. In terms of profitability, RVRC's ROE is +0.07%, compared to ICCO's ROE of +0.17%. Regarding short-term risk, RVRC is less volatile compared to ICCO. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check ICCO's competition here
RVRC vs HSCHF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, HSCHF has a market cap of 1.3K. Regarding current trading prices, RVRC is priced at $1.67, while HSCHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas HSCHF's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to HSCHF's ROE of +1.98%. Regarding short-term risk, RVRC and HSCHF have similar daily volatility (0.00).Check HSCHF's competition here
RVRC vs PCYS Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, PCYS has a market cap of 1.1K. Regarding current trading prices, RVRC is priced at $1.67, while PCYS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas PCYS's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to PCYS's ROE of -2.71%. Regarding short-term risk, RVRC is less volatile compared to PCYS. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check PCYS's competition here
RVRC vs CNONF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, CNONF has a market cap of 1.1K. Regarding current trading prices, RVRC is priced at $1.67, while CNONF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas CNONF's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to CNONF's ROE of +1.60%. Regarding short-term risk, RVRC is less volatile compared to CNONF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check CNONF's competition here
RVRC vs OLMM Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, OLMM has a market cap of 1K. Regarding current trading prices, RVRC is priced at $1.67, while OLMM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas OLMM's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to OLMM's ROE of +4.54%. Regarding short-term risk, RVRC is less volatile compared to OLMM. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check OLMM's competition here
RVRC vs ETAOF Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, ETAOF has a market cap of 512. Regarding current trading prices, RVRC is priced at $1.67, while ETAOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas ETAOF's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to ETAOF's ROE of -13.69%. Regarding short-term risk, RVRC is less volatile compared to ETAOF. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check ETAOF's competition here
RVRC vs LGBI Comparison April 2026
RVRC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVRC stands at 130.8K. In comparison, LGBI has a market cap of 50. Regarding current trading prices, RVRC is priced at $1.67, while LGBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVRC currently has a P/E ratio of -0.35, whereas LGBI's P/E ratio is N/A. In terms of profitability, RVRC's ROE is +0.07%, compared to LGBI's ROE of +0.00%. Regarding short-term risk, RVRC is less volatile compared to LGBI. This indicates potentially lower risk in terms of short-term price fluctuations for RVRC.Check LGBI's competition here